Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
The FDA ended shortage-related compounding in 2025 and, on April 30, 2026, proposed keeping tirzepatide off the 503B bulks list permanently
After your prescription is approved, you'll receive access to video tutorials and written instructions on proper administration technique
People with a history of certain conditionslike medullary thyroid cancer or pancreatitismay not be good candidates
In 2025, two women had to be hospitalized and placed on ventilators after receiving peptide injections at a longevity conference. One was already intubated, and the other had lost muscle control in her neck and couldnt open her eyes or communicate with doctors. Most have no idea theyre playing Russian roulette with contaminated vials
